Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for Endothelial Dysfunction in ACS
NCT04367935Phase 3Completed
- Sponsor
- Ain Shams University
- Start
- Jan 2021
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pentoxifylline in acute coronary syndrome (ACS), sponsored by Ain Shams University. Started Jan 2021; status: completed.
02
Drugs
pentoxifylline
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT04367935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04367935.